4-Bromo-1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacene>95.0%(GC)5g

2-Chloro-N-(4-methoxy-phenyl)-acetamide, 95.0%, 2.5g

2-Ethoxyacetic acid, 95.0%, 500g

alpha-Cyclopentyl-DL-mandelic Acid>98.0%(HPLC)(T)25g

5-Bromo-4-methoxypyridin-2-amine, 95.0%, 25g

4-Amino-6-bromopyrimidine, 95.0%, 1g

(R)-4-Methylisoxazolidin-4-ol hydrochloride, 97%, 100mg

4,4,5,5-tetramethyl-2-(2-methyl-5-nitrophenyl)-1,3,2-dioxaborolane, 95.0%, 100g

3-(1-Methyl-1H-pyrazol-4-yl)-isoxazole-5-carboxylic acid, 95.0%, 1g

Methyl 6-fluoro-1H-indazole-3-carboxylate, 95.0%, 2.5g

2,3-Dichloro-6-fluorobenzaldehyde, 95.0%, 5g

Objetivo Plan PL S100x/1,25. Distancia de trabajo 0,33 mm

DEGUELIN, 95%, 5mg